Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AmbioPharm Opens New Shanghai Campus | Contract Pharma

What are you searching for?

Sign in
Breaking News

AmbioPharm Opens New Shanghai Campus

Adds European executive team members working out of new Zurich office.

By: Contract Pharma

Contract Pharma Staff

AmbioPharm Inc., a provider of peptide API CDMO services, has recently opened its new Shanghai campus. The new campus adds nearly 50,000 square meters of manufacturing, quality control and administrative space.
 
“We have added 4 new buildings which add to our solid-phase and liquid-phase peptide facilities at our Shanghai production site positioning AmbioPharm as the go-to source for all peptide API needs that our partners have. This is in addition to the manufacturing expansion which was completed at our U.S. headquarters in mid-2020,” said Chris Bai, chief executive officer and co-founder, AmbioPharm.
 
Additionally, AmbioPharm has established a new office in Zurich, Switzerland which is headed by Kathleen Noack, vice president of European sales and marketing. Additionally, Michael Postlethwaite, sales director, has joined the AmbioPharm Europe team also working from this new office.
 
“We are delighted to add two highly experienced seasoned professionals to our European team. Both Ms. Noack and Dr. Postlethwaite come with a wealth of peptide API development knowledge to establish and extend our European partnerships,” said Jim Hampton, executive VP of GMP Sales and co-founder.
 
AmbioPharm is a leading and innovation-driven company specializing in the development and manufacture of peptides and peptide-related products. With a comprehensive range of services, AmbioPharm produces custom products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide. Headquartered in the United States of America and with locations in Europe, the USA and Asia, AmbioPharm operates internationally with over 14 years of experience and expertise.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics